Anticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HCl

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-Sung Erlotinib
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Product Name: Erlotinib Hydrochloride
• Name: Erlotinib Hydrochloride Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anthelmintics
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAD No.: 183319-69-9
• Mf: C22h24cln3o4
• Boiling Point: 553.6 C at 760 Mmhg
• Melting Point: 223-225c
• Stored Temperature: -20 C Freezer
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Xi′an Shaanxi
• Production Capacity: 500kg/Month

Product Description

Anticancer CAS 183319-69-9 Erlotinib HCL Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib Hydrochloride

Product Description

Product Details

Product Name	Erlotinib Hydrochloride
Appearance	White Powder
CAD No.	183319-69-9
MF	C22H24ClN3O4

Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer.
Erlotinib hydrochloride should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Uses Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic
Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is a receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).

Application&Function

Erlotinib hydrochloride is a small molecule epidermal growth factor receptor tyrosine kinase reversible inhibitor, mainly used for second-line or third-line treatment of locally advanced or metastatic non-small cell lung cancer and the treatment of pancreatic cancer

Specification